EquityFlowCompanies › Biolevate

Biolevate

healthtech · Paris, FR

AI platform (ELISE) streamlining medical writing.

Funding history

DateRoundAmount
Nov 2024Seed
Paris-based Biolevate raised 6M EUR seed led by EQT Ventures to refine its AI medical-writing platform ELISE.
$6.3M

Investors

BpifranceEQT Ventures

Similar companies in healthtech

Explore funding flow on EquityFlow →